91.7 Ann Arbor/Detroit 104.1 Grand Rapids 91.3 Port Huron 89.7 Lansing 91.1 Flint
Play Live Radio
Next Up:
0:00 0:00
Available On Air Stations

New UM study shows potential for customizing treatment for advanced cancer

outline of human body
Alexander Tokarev
Courtesy of Arul Chinnaiyan
Arul Chinnaiyan’s team analyzed a variety of metastatic cancers throughout the body, including lung cancer (green), breast cancer (pink), and prostate cancer (blue). ";s

Researchers at the University of Michigan Comprehensive Cancer Center have taken a big step forward in understanding how to craft precision treatments for advanced cancer – cancer that has metastasized, or spread.

Using 520 tumor types, they found that in 90 percent of cases, key contributors to an individual patient’s cancer can be identified.

“And that’s important as we think about clinical trials for individual patients," said Dr. Arul Chinnaiyan, senior author of the study.

With a comprehensive understanding of an individual patient’s cancer, Chinnaiyan said, there is the potential of matching them with a clinical trial for a more targeted treatment.

Chinnaiyan, who also directs the Michigan Center for Translational Pathology, joined Stateside host Cynthia Canty to talk about how the findings of the study will improve treatment for advanced cancer.

Listen above.

(Subscribe to the Stateside podcast on iTunes, Google Play, or with this RSS link)

Stateside is produced daily by a dedicated group of producers and production assistants. Listen daily, on-air, at 3 and 8 p.m., or subscribe to the daily podcast wherever you like to listen.
Related Content